Francesco Nannini

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Regulatory T Cells

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Nature communications

Cancer immunology research

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Matteo Righi, Isaac Gannon, Mathew Robson, Saket Srivastava, Evangelia K Kokalaki, Thomas Grothier, Francesco Nannini, Christopher Allen, Yuchen V Bai, James E Sillibourne, Shaun Cordoba, Simon Thomas, Martin A Pule
Enhancing CAR T-cell therapy using Fab-Based Constitutively Heterodimeric Cytokine Receptors. Cancer immunology research (2023)
Ernesto Lopez, Rajesh Karattil, Francesco Nannini, Gordon Weng-Kit Cheung, Lilian Denzler, Felipe Galvez-Cancino, Sergio A Quezada, Martin A Pule
Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignancies. Journal for immunotherapy of cancer 11 (6) (2023)
Giulia Agliardi, Anna Rita Liuzzi, Alastair Hotblack, Donatella De Feo, Nicolás Gonzalo Nuñez, Cassandra L Stowe, Ekaterina Friebel, Francesco Nannini, Lukas Rindlisbacher, Thomas A Roberts, Rajiv Ramasawmy, Iwan P Williams, Bernard M Siow, Mark F Lythgoe, Tammy L Kalber, Sergio A Quezada, Martin A Pule, Sonia Tugues, Karin Straathof, Burkhard Becher
Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma. Nature communications 12 (1) (2021)
Francesco Nannini, Lenart Senicar, Farhaan Parekh, Khai J Kong, Alexander Kinna, Reyisa Bughda, James Sillibourne, Xihao Hu, Biao Ma, Yuchen Bai, Mathieu Ferrari, Martin A Pule, Shimobi C Onuoha
Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments. mAbs 13 (1) (2021)